---
title: "MW Bio-B (2493.HK) surged over 5% intraday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284712125.md"
description: "MABWELL-B (2493.HK) current price is 26.840, up 5.34% for the day, with an intraday increase exceeding 5%, and a market capitalization of 12 billion. The company focuses on the research and development of innovative drugs, and its first-day closing performance was outstanding. Recently, it will showcase cervical cancer clinical data at ESMO GC, with the new pipeline becoming a market focus. There are no other significant catalysts at the moment, and stock price fluctuations may be influenced by capital demand"
datetime: "2026-04-30T07:00:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284712125.md)
  - [en](https://longbridge.com/en/news/284712125.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284712125.md)
---

# MW Bio-B (2493.HK) surged over 5% intraday

MW Bio-B (2493.HK) is trading at HK$26.840, up **+5.34%** on the day, with a market cap of HK$12 billion.

The company specializes in innovative pharmaceuticals and delivered a strong debut performance. Upcoming presentations at ESMO GC will highlight new cervical cancer clinical data, spotlighting its pipeline. No additional major catalysts reported; the stock movement may reflect short-term investor enthusiasm.

### Related Stocks

- [02493.HK](https://longbridge.com/en/quote/02493.HK.md)

## Related News & Research

- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [Mabwell says China NMPA clears MAIWEIJIAN denosumab for bone metastases, myeloma](https://longbridge.com/en/news/287132345.md)
- [Some May Be Optimistic About Coloplast's (CPH:COLO B) Earnings](https://longbridge.com/en/news/287005062.md)
- [Release according to article 135 section 2 BörseG](https://longbridge.com/en/news/286754366.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)